Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1249 (LINC01249) is a long non-coding RNA (lncRNA), specifically classified as a long intergenic non-protein coding RNA (lincRNA), meaning it is transcribed from the genome but does not encode a protein[1][5]. LINC01249 is expressed upstream of SOX11, a gene important for embryonic neurogenesis and tissue modeling, and its expression may be linked to the regulation of SOX11 expression in certain tissues such as the fetal testis[5]. There is no evidence that LINC01249 functions as a therapeutic target (such as a receptor, enzyme, or transporter), nor are there any drugs known to directly interact with it or mechanisms of action defined for pharmacological targeting[1][5]. The main known function of LINC01249, in line with other lincRNAs, is the potential regulation of gene expression at the transcriptional or post-transcriptional level; its specific biological functions and disease associations remain largely uncharacterized, with indirect evidence pointing to a role in development through its regulation of nearby genes[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1249 (LINC01249).